LIGAND PHARMACEUTICALS INC Quarterly Current Ratio in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Ligand Pharmaceuticals Inc quarterly Current Ratio history and growth rate from Q1 2012 to Q2 2024.
  • Ligand Pharmaceuticals Inc Current Ratio for the quarter ending June 30, 2024 was 1.7K %, a 466% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 1.7K +1.4K +466% Jun 30, 2024
Q1 2024 1.43K +1.22K +576% Mar 31, 2024
Q4 2023 682 +456 +202% Dec 31, 2023
Q3 2023 462 +151 +48.6% Sep 30, 2023
Q2 2023 301 -191 -38.8% Jun 30, 2023
Q1 2023 211 -704 -77% Mar 31, 2023
Q4 2022 226 -545 -70.7% Dec 31, 2022
Q3 2022 311 -314 -50.3% Sep 30, 2022
Q2 2022 491 -268 -35.3% Jun 30, 2022
Q1 2022 915 -78.9 -7.94% Mar 31, 2022
Q4 2021 771 -818 -51.5% Dec 31, 2021
Q3 2021 626 -2.75K -81.5% Sep 30, 2021
Q2 2021 759 -3.15K -80.6% Jun 30, 2021
Q1 2021 994 -1.52K -60.5% Mar 31, 2021
Q4 2020 1.59K +63.1 +4.14% Dec 31, 2020
Q3 2020 3.37K +2.15K +175% Sep 30, 2020
Q2 2020 3.91K +3.43K +714% Jun 30, 2020
Q1 2020 2.51K +2.18K +653% Mar 31, 2020
Q4 2019 1.53K +1.27K +503% Dec 31, 2019
Q3 2019 1.22K +1.02K +514% Sep 30, 2019
Q2 2019 480 +311 +183% Jun 30, 2019
Q1 2019 334 +227 +213% Mar 31, 2019
Q4 2018 253 +163 +181% Dec 31, 2018
Q3 2018 199 +116 +139% Sep 30, 2018
Q2 2018 170 +95.1 +128% Jun 30, 2018
Q1 2018 107 +39.6 +59% Mar 31, 2018
Q4 2017 90.2 +8.08 +9.84% Dec 31, 2017
Q3 2017 83.3 -6.97 -7.72% Sep 30, 2017
Q2 2017 74.6 -70.6 -48.6% Jun 30, 2017
Q1 2017 67.2 -213 -76% Mar 31, 2017
Q4 2016 82.1 -213 -72.2% Dec 31, 2016
Q3 2016 90.2 -953 -91.4% Sep 30, 2016
Q2 2016 145 -853 -85.5% Jun 30, 2016
Q1 2016 280 -494 -63.8% Mar 31, 2016
Q4 2015 296 -256 -46.4% Dec 31, 2015
Q3 2015 1.04K +715 +218% Sep 30, 2015
Q2 2015 999 +896 +875% Jun 30, 2015
Q1 2015 774 +697 +895% Mar 31, 2015
Q4 2014 551 +493 +848% Dec 31, 2014
Q3 2014 328 +274 +502% Sep 30, 2014
Q2 2014 102 +46.3 +82.3% Jun 30, 2014
Q1 2014 77.8 +15.8 +25.5% Mar 31, 2014
Q4 2013 58.1 -11.5 -16.5% Dec 31, 2013
Q3 2013 54.5 -17.2 -24% Sep 30, 2013
Q2 2013 56.2 -15.8 -21.9% Jun 30, 2013
Q1 2013 62 -9.14 -12.8% Mar 31, 2013
Q4 2012 69.6 Dec 31, 2012
Q3 2012 71.7 Sep 30, 2012
Q2 2012 71.9 Jun 30, 2012
Q1 2012 71.2 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.